Abstract:The biological function of the natural ent-kaurene diterpenoid isolated from genus Isodon, oridonin, has been intensively studied. However, its mechanism studies and clinical applications were hampered by its moderate biological activities. In order to enlarge the applied range of oridonin and explore its mechanism of action, a series of derivatives were designed and synthesized based on the structure of oridonin. Some of the derivatives were significantly more potent than oridonin against four cancer cell lines. Especially, the most potent compound 20 markedly inhibited the proliferation of well differentiated HepG2 and poorly differentiated PLC/PRF/5 cells, with IC50 values as low as 1.36 μM and 0.78 μM respectively, while the IC50 values of oridonin are 8.12 μM and 7.41 μM. We found that compound 20 inhibited liver cancer cell proliferation via arresting cell cycle at G1 phase. Moreover, it induced liver cancer cell apoptosis by decreasing the mitochondrial membrane potential, increasing intracellular reactive oxygen species level and inducing the expression of apoptosis-related proteins. Furthermore, compound 20 significantly inhibited growth of PLC/PRF/5 xenograft tumors in nude mice and had no observable toxic effect. Altogether, these results indicated that compound 20 is a promising lead for liver cancer therapeutics.

Synthesis of spirolactone-type diterpenoid derivatives from kaurene-type oridonin with improved antiproliferative effects and their apoptosis-inducing activity in human hepatoma Bel-7402 cells.

Enmein-Type Diterpenoid Analogs from Natural Kaurene-Type Oridonin: Synthesis and Their Antitumor Biological Evaluation

Novel Nitric Oxide-Releasing Spirolactone-Type Diterpenoid Derivatives with in Vitro Synergistic Anticancer Activity As Apoptosis Inducer

The Conversion of Oridonin to Spirolactone-Type or Enmein-Type Diterpenoid: Synthesis and Biological Evaluation of Ent-6,7-seco-oridonin Derivatives As Novel Potential Anticancer Agents.

Spirolactone-type and Enmein-Type Derivatives As Potential Anti-Cancer Agents Derived from Oridonin

Oridonin Derivatives As Potential Anticancer Drug Candidates Triggering Apoptosis Through Mitochondrial Pathway in the Liver Cancer Cells

Identification of New Potent Anticancer Derivatives Through Simplifying the Core Structure and Modification on Their 14- Hydroxyl Group from Oridonin.

Synthesis and Biological Evaluation of Novel 1-O- and 14-O-derivatives of Oridonin As Potential Anticancer Drug Candidates

Synthesis And Evaluation Of New Podophyllotoxin Derivatives With In Vitro Anticancer Activity

Synthesis and Anti-tumor Activity of 14-O-derivatives of Natural Oridonin

Synthesis and Antitumor Activity of a Series of Novel 1-Oxa-4-azaspiro[4,5]deca-6,9-diene-3,8-dione Derivatives

Design and synthesis of novel oridonin analogues as potent anticancer agents.

Synthesis of oridonin derivatives and their inhibition on t(8;21) leukemia

Synthesis and biological evaluation of novel Jiyuan Oridonin A-1,2,3-triazole-azole derivatives as antiproliferative agents.

A Novel Potent Anticancer Compound Optimized from a Natural Oridonin Scaffold Induces Apoptosis and Cell Cycle Arrest Through the Mitochondrial Pathway

Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 14-Substituted Oridonin Analogs: A Novel and Potent Cell Cycle Arrest and Apoptosis Inducer Through the P53-Mdm2 Pathway.

Synthesis and anticancer activity of new spirooxindoles incorporating[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine moiety

Design, Synthesis and Biological Evaluation of Novel Antitumor Spirodihydrothiopyran-Oxindole Derivatives

Novel Nitrogen-Enriched Oridonin Analogues with Thiazole-Fused A-Ring: Protecting Group-Free Synthesis, Enhanced Anticancer Profile, and Improved Aqueous Solubility

An expedient multi‐component synthesis of pyridinyl‐spirooxindoles and their effect on proliferation of lung cancer A549 cells

Discovery of Novel Polycyclic Spiro-Fused Carbocyclicoxindole-Based Anticancer Agents